IP Library › Assignment 069483/0431
Patent Assignment
Reel/Frame 069483/0431

Assignment of Assignor's Interest

Recorded: 2024-12-04 Pages: 3
Assignor
NUCHEM THERAPEUTICS, INC.
Executed: 2021-06-18
Assignee
SENDA BIOSCIENCES, INC.
20 ACORN PARK DRIVE, SUITE 300, CAMBRIDGE, MASSACHUSETTS, 02140
Covered Property (1)
Fused Imidazole Derivatives as Ahr Antagonists
Application: 17/999,254 →
Publication: US 2023/0331705
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 4, 2024
From: MANCUSO, JOHN; BOS, MAXENCE; LY, VU LINH
To: NUCHEM THERAPEUTICS, INC.
Reel/Frame 069483/0413 →
Assignment of Assignor's Interest Dec 4, 2024
From: BARTOLOZZI, ALESSANDRA; PROUDFOOT, JOHN ROBERT; BRIGGS, TIMOTHY; BLOIS, ANNA
To: SENDA BIOSCIENCES, INC.
Reel/Frame 069483/0527 →
Assignment of Assignor's Interest Dec 4, 2024
From: SENDA BIOSCIENCES, INC.
To: SAIL BIOMEDICINES, INC.
Reel/Frame 069483/0509 →